Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cardio Diagnostics Holdings (CDIOW) Return on Equity (2022 - 2025)

Historic Return on Equity for Cardio Diagnostics Holdings (CDIOW) over the last 4 years, with Q3 2025 value amounting to 0.73%.

  • Cardio Diagnostics Holdings' Return on Equity rose 17100.0% to 0.73% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.73%, marking a year-over-year increase of 17100.0%. This contributed to the annual value of 1.34% for FY2024, which is 9700.0% up from last year.
  • Cardio Diagnostics Holdings' Return on Equity amounted to 0.73% in Q3 2025, which was up 17100.0% from 0.59% recorded in Q2 2025.
  • In the past 5 years, Cardio Diagnostics Holdings' Return on Equity registered a high of 0.24% during Q2 2022, and its lowest value of 3.84% during Q1 2024.
  • Moreover, its 4-year median value for Return on Equity was 1.27% (2024), whereas its average is 1.66%.
  • In the last 5 years, Cardio Diagnostics Holdings' Return on Equity plummeted by -33500bps in 2023 and then soared by 32800bps in 2025.
  • Over the past 4 years, Cardio Diagnostics Holdings' Return on Equity (Quarter) stood at 0.67% in 2022, then crashed by -375bps to 3.19% in 2023, then skyrocketed by 60bps to 1.27% in 2024, then surged by 42bps to 0.73% in 2025.
  • Its Return on Equity stands at 0.73% for Q3 2025, versus 0.59% for Q2 2025 and 0.56% for Q1 2025.